Loading...
•
Dec 31, 2020
Globus Medical Q4 2020 Earnings Report
Globus Medical's Q4 2020 results were announced, featuring a 10.3% increase in worldwide net sales and GAAP net income reaching $53.0 million.
Key Takeaways
Globus Medical reported a strong fourth quarter in 2020, with worldwide net sales increasing by 10.3% compared to the same period in 2019. The growth was driven by Enabling Technologies and US Spine. The company's GAAP net income for the quarter was $53.0 million, and non-GAAP diluted EPS was $0.58.
Worldwide net sales increased by 10.3% compared to Q4 2019, reaching $233.4 million.
GAAP net income for the quarter was $53.0 million, representing 22.7% of net sales.
GAAP diluted EPS was $0.52, while non-GAAP diluted EPS was $0.58.
Enabling Technologies led growth, up 30% in the quarter, with US Spine growing by 12%.
Globus Medical
Globus Medical
Globus Medical Revenue by Segment
Globus Medical Revenue by Geographic Location
Revenue by Segment
Musculoskeletal Solutions Revenue
CapyFin.comEnabling Technologies Revenue
CapyFin.comRevenue by Geographic Location
United States Revenue
CapyFin.comInternational Revenue
CapyFin.com Forward Guidance
The Company announced full year 2021 guidance with expected net sales of $880 million and non-GAAP diluted earnings per share of $1.83.
Positive Outlook
- Expected net sales of $880 million for full year 2021.
- Non-GAAP diluted earnings per share of $1.83 for full year 2021.
Revenue & Expenses
Visualization of income flow from segment revenue to net income